Epidemiological and Clinical Characteristics of Right versus Left Colorectal Cancer

Overview

This study investigates the clinical and epidemiological characteristics of cachexia in colorectal cancer patients, focusing on differences between right- and left-sided tumors. Findings indicate that cachectic patients exhibit distinct inflammatory and nutritional profiles.

Background

Colorectal cancer (CRC) is a leading cause of cancer-related morbidity and mortality globally. Understanding the differences in clinical outcomes between right-sided and left-sided tumors is crucial.

Data Highlights

Key Findings

• Cachectic patients had significantly lower BMI, hemoglobin, and albumin levels.
• Higher CRP concentrations and CRP/albumin ratios were observed in cachectic patients.
• Cachexia was more frequent among patients with right-sided tumors, though not statistically significant.
• Patients who died during follow-up were significantly older than survivors.
• Accessible biomarkers like CRP and albumin are relevant for patient assessment and risk stratification.

Clinical Implications

The distinct profiles of cachectic patients suggest the need for further investigation into their management.

Conclusion

Further research is needed to explore the prognostic implications of these findings.

Related Resources & Content

1. Author(s)/Org, Source, Year -- Title
2. Author(s)/Org, Source, Year -- Title
3. Author(s)/Org, Source, Year -- Title
4. Author(s)/Org, Source, Year -- Title
5. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
6. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial | Trials | JAMA | JAMA Network
7. Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies | npj Precision Oncology
8. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up☆
9. Panitumumab vs Bevacizumab Added to Standard First-line Chemotherapy and Overall Survival Among Patients With RAS Wild-type, Left-Sided Metastatic Colorectal Cancer: A Randomized Clinical Trial | Trials | JAMA | JAMA Network
10. Multidimensional differences of right- and left-sided colorectal cancer and their impact on targeted therapies | npj Precision Oncology